Director Bethany Mayer filed a Form 4 with the SEC on November 9, 2026, disclosing transactions in Lam Research Corp common stock dated November 6, 2026, including an award of restricted stock units and a sale under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Award received: Bethany Mayer acquired 856 shares of common stock at $0 on November 6, 2026, in a transaction coded "A."
  • Shares sold: 16 shares were disposed of at $208.50 per share on November 6, 2026, under a Rule 10b5-1 plan.
  • Direct holdings after transactions: Mayer directly held 1,756 shares of common stock following the reported transactions, with the reported total including shares subject to unvested restricted stock units.
  • Indirect holdings: Mayer also held 20,995 shares indirectly through a trust.
  • 10b5-1 plan date: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2025.
  • Filing signed: The form was signed by Marta Woods by Power of Attorney on November 9, 2026.

Bethany Mayer's November 2026 Transactions in Lam Research Common Stock

According to the Form 4 filed on November 9, 2026, Bethany Mayer, a director of Lam Research Corp (NASDAQ:LRCX), reported two transactions in the company's common stock, both dated November 6, 2026. The first was an acquisition of 856 shares at a price of $0, consistent with a grant of restricted stock units, as the filing notes that "the amount reported includes shares subject to unvested restricted stock units."

The second transaction was a sale of 16 shares at $208.50 per share. The filing states that "this transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2025." Following both transactions, Mayer directly held 1,756 shares. The filing also indicates Mayer indirectly holds 20,995 shares through a trust, with no changes to that position reported in this filing.

The form was filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, covering changes in beneficial ownership by a director of the issuer. The box on the form indicating the transaction was made pursuant to a Rule 10b5-1(c) plan was checked, applying to the sale transaction. No derivative securities were reported in Table II of the filing.

What Was Disclosed

Lam Research Corp director Bethany Mayer disclosed the acquisition of 856 shares at $0 and the sale of 16 shares at $208.50 on November 6, 2026. Direct beneficial ownership stood at 1,756 shares after the transactions, with 20,995 additional shares held indirectly through a trust.